Literature DB >> 18495435

Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).

Richard S E Keefe1, Philip D Harvey, Terry E Goldberg, James M Gold, Trina M Walker, Courtney Kennel, Kirsten Hawkins.   

Abstract

According to the recommendations of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Neurocognition Committee, one of the desired characteristics of a cognitive battery for assessing cognition in schizophrenia studies and clinical trials is the availability of normative data. This report describes normative data collected on the Brief Assessment of Cognition in Schizophrenia (BACS) from 404 healthy controls with demographic characteristics matching the 2005 United States Census of English-speakers. The six test measures demonstrated the expected pattern of correlations with age, gender, and education. Individual test scores were converted into standardized (T and z) scores and composite scores that were corrected for age and gender. An education-correction factor was calculated and recommended only for non-schizophrenia patients. Eight different verbal memory tests were found to have equivalent levels of difficulty.

Entities:  

Mesh:

Year:  2008        PMID: 18495435     DOI: 10.1016/j.schres.2008.03.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  104 in total

1.  Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Authors:  Tyler Grove; Stephan Taylor; Gregory Dalack; Vicki Ellingrod
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

2.  Neural correlates of global and specific cognitive deficits in schizophrenia.

Authors:  Robert J Jirsaraie; Julia M Sheffield; Deanna M Barch
Journal:  Schizophr Res       Date:  2018-06-25       Impact factor: 4.939

3.  Neural complexity as a potential translational biomarker for psychosis.

Authors:  Brandon Hager; Albert C Yang; Roscoe Brady; Shashwath Meda; Brett Clementz; Godfrey D Pearlson; John A Sweeney; Carol Tamminga; Matcheri Keshavan
Journal:  J Affect Disord       Date:  2016-10-26       Impact factor: 4.839

4.  Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo.

Authors:  Lone Baandrup; Birgitte Fagerlund; Birte Glenthoj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-11       Impact factor: 5.270

5.  Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study.

Authors:  Rebekka Lencer; Andreas Sprenger; James L Reilly; Jennifer E McDowell; Leah H Rubin; Judith A Badner; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; John A Sweeney
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

6.  Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders.

Authors:  Rebekka Lencer; Li Yao; James L Reilly; Sarah K Keedy; Jennifer E McDowell; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; Su Lui; John A Sweeney
Journal:  Hum Brain Mapp       Date:  2018-09-10       Impact factor: 5.038

7.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

8.  Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.

Authors:  Jeong Lan Kim; Shilpa Rele; David M Marks; Prakash S Masand; Pallavi Yerramsetty; Robert A Millet; Richard S Keefe; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-26

9.  Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Authors:  Julie Eve Desmarais; Linda Beauclair; Lawrence Annable; Marie-Claire Bélanger; Theodore T Kolivakis; Howard C Margolese
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

10.  Differential effects of emotional information on interference task performance across the life span.

Authors:  Haley M Lamonica; Richard S E Keefe; Philip D Harvey; James M Gold; Terry E Goldberg
Journal:  Front Aging Neurosci       Date:  2010-09-30       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.